| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |